指南与共识泌尿生殖技术与安全CT

患者报告风险因素在门诊CT前识别晚期慢性肾病的效用:与近期ACR/NKF共识标准的比较

Utility of Patient-Reported Risk Factors for Identifying Advanced Chronic Kidney Disease Before Outpatient CT: Comparison With Recent ACR/NKF Consensus Criteria.
指南 / 共识 · AJR Am J Roentgenol · 2022-04-06

本回顾性研究在实施电子筛查表的医疗系统中,评估患者报告风险因素对识别门诊CT前估算肾小球滤过率(eGFR)低于30 mL/min/1.73 m²的效用。44,708例完成筛查表的患者中,10,256例在CT当天接受eGFR检测,仅1.4% eGFR低于30;透析、肾病和药物治疗的糖尿病是独立预测因素。若采用ACR/NKF标准,需检测人数减少89.7%,但47.2%的低eGFR患者会被漏诊。

要点

  • 患者报告风险因素筛查导致频繁eGFR检测,但低eGFR检出率仅1.4%。
  • 仅透析、肾病和药物治疗的糖尿病是低eGFR的独立预测因素。
  • 采用ACR/NKF标准可大幅减少检测量,但会漏诊47.2%的低eGFR患者。

核心结论

  • 使用患者报告风险因素导致频繁eGFR检测但低eGFR检出率低,常用风险因素未独立关联低eGFR;应用ACR/NKF标准将大幅减少eGFR检测但会漏诊肾功能不全患者,声明应考虑省略肾脏手术作为触发因素并将糖尿病作为必需触发因素。

研究设计与样本

  • 回顾性研究,在实施电子筛查表的医疗系统中进行;44,708例患者完成筛查表(2020年6月1日至2021年2月28日),其中10,256例(5315男,4941女;平均年龄66.8±11.9岁;范围21-98岁)在CT当天接受eGFR检测;采用多变量回归分析预测eGFR降低,并与 theoretic 使用ACR/NKF标准的结果比较。

诊断标准与关键数值

  • 低eGFR定义为eGFR低于30 mL/min/1.73 m²;同日检测中1.4%(144/10,256)患者eGFR低于30;低eGFR的显著独立预测因素:透析(OR 203.30)、肾病(OR 12.55)、药物治疗的糖尿病(OR 2.44);若遵循ACR/NKF标准(仅肾病,定义为透析、肾病或既往肾脏手术)作为eGFR检测触发因素,需检测患者数从10,256降至1059(减少89.7%),检出率升至7.2%(76/1059),47.2%(68/144)低eGFR患者被漏诊;若遵循ACR/NKF标准但将糖尿病视为必需而非可选标准,需检测患者数降至2353(减少77.1%),检出率升至4.0%(95/2353),34.0%(49/144)低eGFR患者被漏诊。

临床应用与阅片要点

  • 作者认为ACR/NKF声明应考虑省略肾脏手术作为eGFR检测触发因素,并将糖尿病作为必需触发因素。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Practices vary for screening patients for risk of renal dysfunction before administration of iodinated contrast medium. A 2020 American College of Radiology/National Kidney Foundation (ACR/NKF) consensus statement provided streamlined screening criteria. OBJECTIVE. The purpose of this study was to assess the yield of patient-reported risk factors for identifying estimated glomerular filtration rate (eGFR) less than 30 mL/min/1.73 m2 before outpatient CT. METHODS. This retrospective study was performed at a health system that implemented an electronic screening form for patients to complete before outpatient CT encounters to report undergoing dialysis, taking cancer-treating medications, having kidney disease, undergoing prior kidney surgery, having diabetes mellitus treated with medication, having hypertension treated with medication, or having multiple myeloma. Patients with any risk factor were required to undergo eGFR testing before CT. Of 44,708 patients completing the form from June 1, 2020, through February 28, 2021, 10,256 patients (5315 men, 4941 women; mean age, 66.8 ± 11.9 [SD] years; range, 21-98 years) underwent eGFR testing on the day of CT. Multivariable regression analysis for predicting reduced eGFR was performed. Findings were compared with those from theoretic use of the ACR/NKF criteria. RESULTS. Same-day testing yielded eGFR less than 30 mL/min/1.73 m2 in 1.4% (144/10,256) of patients. The only significant independent predictors of low eGFR were dialysis (odds ratio [OR], 203.30], kidney disease (OR, 12.55), and diabetes mellitus treated with medication (OR, 2.44). If the ACR/NKF criteria (only kidney disease, defined as dialysis, kidney disease, or prior kidney surgery) had been followed as a trigger for eGFR testing, the number of patients needing testing would have decreased 89.7%, from 10,256 to 1059; yield would have increased to 7.2% (76/1059); and 47.2% (68/144) of patients with low eGFR would have been missed. If the ACR/NKF criteria had been followed but diabetes mellitus been considered a required rather than an optional criterion, the number of patients needing testing would have decreased 77.1%, to 2353; yield would have increased to 4.0% (95/2353); and 34.0% (49/144) of patients with low eGFR would have been missed. CONCLUSION. Using patient-reported risk factors resulted in frequent eGFR testing but low yield of low eGFR. Commonly applied risk factors were not independently associated with low eGFR. CLINICAL IMPACT. Application of ACR/NKF criteria would substantially reduce eGFR testing, but patients with renal dysfunction would be missed. The statement should consider omitting kidney surgery as a trigger for eGFR testing and including diabetes mellitus as a required trigger.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Abbasi, Glazer, Saini, et al. Utility of Patient-Reported Risk Factors for Identifying Advanced Chronic Kidney Disease Before Outpatient CT: Comparison With Recent ACR/NKF Consensus Criteria. AJR Am J Roentgenol. 2022. PMID: 35383485. doi:10.2214/AJR.22.27494

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。